For infants with cerebral palsy, 60 hours of play-based therapy produces lasting gains - regardless of approach

The brain of a child under two years old is remarkably malleable. Neurons are forming new connections at rates that will never be matched later in life, and experiences during this window shape motor development in ways that become increasingly difficult to alter. For children with unilateral cerebral palsy - a condition affecting the brain's control of muscles on one side of the body - this plasticity represents both a challenge and an opportunity.

The challenge: without intervention, the developing brain may increasingly neglect the affected side, reinforcing patterns of one-handed function. The opportunity: intensive therapy during this critical period could redirect development before those patterns solidify.

The Baby CHAMP trial, led by researchers at Virginia Tech's Fralin Biomedical Research Institute, is the first randomized controlled study to compare multiple intensive therapy approaches head-to-head in infants and toddlers aged 6 to 24 months. The results suggest that the specific approach matters less than simply delivering enough therapy, early enough.

Three approaches, one protocol

The study compared three therapist-delivered interventions. Two were forms of constraint-induced movement therapy (CIMT), which restricts the stronger arm to force use of the weaker one during therapy sessions. One version used a full-time cast on the stronger arm; the other used a splint worn only during sessions. The third approach was bimanual therapy, which promotes coordinated use of both hands without any constraint.

All children received the same dose: three hours of structured, play-based therapy per day, five days a week, for four consecutive weeks - totaling 60 hours. Parents also supported additional guided practice at home.

Fifty-eight children were enrolled across multiple sites, including Virginia Tech, The Ohio State University, and Nationwide Children's Hospital. Fifty-three completed treatment and end-of-therapy assessments, and 41 returned for evaluation six months later.

Similar gains across the board

The findings upended the researchers' own hypotheses. They had predicted that bimanual therapy would produce greater improvements in two-handed skills, and that full-time casting would yield stronger gains specifically in the affected arm. Neither prediction held.

Instead, children in all three groups showed significant improvements in the ability to use both hands individually and together, measured by standardized developmental assessments administered by evaluators blinded to treatment assignment. Gains in fine motor skills in the less-affected arm were observed across all groups. And improvements were most pronounced at the six-month follow-up, indicating that benefits continued building after formal therapy ended.

Stephanie DeLuca, associate professor at the Fralin Biomedical Research Institute and co-principal investigator, described the results as offering families and clinicians evidence-based options. The encouraging message, she said, is that early intensive therapy works and multiple approaches can help children build critical motor skills.

No harm from constraining the stronger arm

One persistent concern in the field has been whether constraining the stronger arm during a critical developmental period might impair its development. The Baby CHAMP data found no evidence of harm. In fact, children in the full-time cast group showed slightly greater gains in fine motor skills in their non-affected arm at the six-month mark compared to the bimanual group.

Some parents reported short-term frustration when their child wore a cast or splint, and minor skin irritation occurred in a small number of children using casts. But no injuries resulted from the therapy itself.

Small trial, important signal

The study has significant limitations that the researchers acknowledge openly. With 58 children enrolled and 41 completing the six-month follow-up, the sample is small - too small to detect modest differences between treatments if they exist. The study was powered to compare within-group improvements rather than to definitively determine superiority of one approach over another.

The six-month follow-up period, while encouraging, doesn't tell us whether gains persist into school age or beyond. Sharon Landesman Ramey, co-principal investigator and Virginia Tech Distinguished Scholar, noted that longer-term studies will be needed to understand how early therapy influences development across many dimensions of a child's life.

The trial population - infants and toddlers with confirmed unilateral cerebral palsy - represents a specific subset of children with motor impairments, and results may not generalize to children with bilateral involvement or other neurological conditions.

Dose and timing may matter more than technique

The broader takeaway from Baby CHAMP aligns with a theme emerging across rehabilitation science: for very young children with neurological conditions, the dose and timing of therapy may matter more than the specific technique used. Sixty hours of structured, play-based intervention during the period of maximum brain plasticity produced meaningful, lasting improvements - regardless of whether the therapist constrained the stronger arm with a cast, used a session-only splint, or worked on two-handed skills directly.

For families navigating early cerebral palsy diagnosis, this is practical information. It means the choice between therapeutic approaches can be guided by the child's temperament, the family's preferences, and practical considerations - without sacrificing efficacy. And it underscores that the most important variable may be simply starting early and doing enough.